TransMedics (TMDX) Cash from Operations (2018 - 2026)
TransMedics has reported Cash from Operations over the past 8 years, most recently at 34513000.0 for Q4 2025.
- For Q4 2025, Cash from Operations rose 75.52% year-over-year to 34513000.0; the TTM value through Dec 2025 reached 192840000.0, up 295.14%, while the annual FY2025 figure was 192840000.0, 295.14% up from the prior year.
- Cash from Operations for Q4 2025 was 34513000.0 at TransMedics, down from 69573000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 91609000.0 in Q2 2025 and troughed at 18406000.0 in Q1 2022.
- A 5-year average of 7696700.0 and a median of 4785500.0 in 2021 define the central range for Cash from Operations.
- Biggest five-year swings in Cash from Operations: plummeted 151.11% in 2022 and later surged 914.63% in 2025.
- Year by year, Cash from Operations stood at 6648000.0 in 2021, then surged by 39.31% to 4035000.0 in 2022, then surged by 305.8% to 8304000.0 in 2023, then surged by 136.79% to 19663000.0 in 2024, then soared by 75.52% to 34513000.0 in 2025.
- Business Quant data shows Cash from Operations for TMDX at 34513000.0 in Q4 2025, 69573000.0 in Q3 2025, and 91609000.0 in Q2 2025.